Clinical Trials Logo

Filter by:
NCT ID: NCT04981366 Completed - Aging Clinical Trials

Protein Supplementation in Elderly With Sarcopenic Obesity Undergoing Caloric Restriction and Exercise

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

This study aims to investigate if protein supplementation increases the benefits of exercise training in the elderly with sarcopenic obesity undergoing caloric restriction.

NCT ID: NCT04980586 Completed - Clinical trials for Obstructive Sleep Apnea

Cheeks Appearance as a Novel Predictor of Obstructive Sleep Apnea The CASA Score Study

CASA
Start date: January 10, 2019
Phase:
Study type: Observational

Cheeks appearance is a screening tool developed based on cheeks observation to identify volume, flaccidity or both to predict people with probable obstructive sleep apnea.

NCT ID: NCT04980274 Completed - Clinical trials for Critically Ill Patients

Impact of Admission SOFA Score and 48-hour Delta SOFA on Clinical Outcomes in Critically Ill Patients

Start date: January 1, 2020
Phase:
Study type: Observational

Organ dysfunctions are associated with high morbidity and mortality. The SOFA (Sequential Organ Failure Assessment) score developed by Vincent et al. sequentially assesses the presence and severity of dysfunctions in six organ systems: respiratory, cardiovascular, coagulation, hepatic, neurological and renal. Although the SOFA score was created to quantify organ dysfunctions, the obvious relationship between organ dysfunctions and mortality has been widely documented. Dynamic measurements of the SOFA score assess response to treatment and can be used to search for perpetuating sources of severity and reassess the treatment plan. The primary objective of this study will be to assess the impact of an admission SOFA score equal to or greater than 2 and subsequent interventions on outcomes related to the 48-hour delta SOFA on ICU and hospital mortality, length of stay in the ICU, duration of mechanical ventilation, time of vasoactive drug use. Patients will be divided into three groups: those who did not trigger the SOFA trigger on admission to the ICU (Group 1), those who triggered the SOFA trigger and improved on the third day (Group 2) and, finally, those who triggered the SOFA trigger and worsened on the third day (Group 3).

NCT ID: NCT04973449 Completed - COVID-19 Clinical Trials

Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults

AZD2816
Start date: June 27, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of the study is to assess the safety, and immunogenicity of AZD2816 for the prevention of COVID-19

NCT ID: NCT04969549 Completed - Depression Clinical Trials

Response Predictors of Theta-burst Stimulation for Depression

TBS
Start date: May 13, 2021
Phase: N/A
Study type: Interventional

The study consists of an open label trial designed to treat adult depression with TBS. Our aim is to build capacity in neuroimaging analyses by performing magnetic resonance imaging (MRI) assessments at baseline and after 7-10 days of treatment onset in 70 patients. The scientific goal is to test a hypothesis about treatment action: that TBS will reduce negative bias (which causally maintains negative mood) after 1 week of treatment, and patients who show this neurocognitive change will be the ones who go on to respond clinically after 6 weeks.

NCT ID: NCT04967859 Completed - Clinical trials for Hemodialysis Catheter Infection

Evaluation of the Efficacy of Prophylactic Topical Gentamicin in Tunnelled Catheters for Hemodialysis

Start date: July 1, 2018
Phase: Phase 1
Study type: Interventional

Chronic kidney disease (CKD) is a major public health problem worldwide, with a significant increase in the number of patients treated with dialysis and renal transplantation. Hemodialysis (HD) is the most widely used dialysis therapy in the world, and adequate vascular access is required. The central venous catheter (CVC), although not considered the ideal vascular access, is still widely used. Its use has a strong relation with access-related infection, whether it is an exit orifice (IES), a tunnel and the most severe, the bloodstream (BSI). Consequently CVC contributes to patients' morbidity and mortality in HD, as well as to the high cost of hemodialysis treatment. To compare the use of 0.1% topical gentamicin with the use of placebo in the exit site (ES) of tunneled catheters in patients in chronic HD regarding the reduction in IES and BSI rates and to identify the induction of bacterial resistance to gentamicin.

NCT ID: NCT04967235 Completed - Clinical trials for Cardiovascular Diseases

Dance Therapy as an Alternative for Cardiac Rehabilitation in Women Population

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

This research project aims to investigate the acute effects of a dance-based cardiac rehabilitation session in the cardiovascular system and autonomic modulation of women with cardiac risk factors. Also, as a secondary outcome, to compare the cardiovascular and autonomic responses of the dance-based session to a conventional exercise-based session.

NCT ID: NCT04966923 Completed - Breast Cancer Clinical Trials

Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53

BREAST-TP53
Start date: December 2, 2018
Phase:
Study type: Observational

A prospective and retrospective cohort study of patients with a documented pathogenic or likely pathogenic variants of TP53 were identified using blood DNA colection and breast cancer diagnosis by histological confirmation, between 1999 and 2022. All patients were followed by the Hereditary Group of a single cancer center (Instituto do Cancer do Estado de Sao Paulo). Patients were included if they had a histopathological diagnosis of localized invasive carcinoma or in situ carcinoma of the breast and with localized disease. Patients met Revised Chompret criteria, Li Fraumeni like syndrome,family member of carrier TP53 or hereditary breast and ovarian syndrome for germline test.

NCT ID: NCT04964908 Completed - Clinical trials for Chronic Lymphocytic Leukemia

Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia

CREEK
Start date: December 3, 2021
Phase:
Study type: Observational

A Multicenter Retrospective Study to understand the clinical characteristics, treatment pathway and resource utilization for patients with chronic lymphocytic leukemia A retrospective, multi-centre, observational study to describe disease characteristics, treatment patterns, treatment-related outcomes, and resource utilization for Chronic Lymphocytic Leukemia (CLL) patients in multiple international regions

NCT ID: NCT04963829 Completed - Chronic Ulcer Clinical Trials

Unripe Banana Peel Powder and Lemongrass Oil in Chronic Ulcer

Start date: February 2, 2018
Phase: Phase 1
Study type: Interventional

To evaluate the activity of a gel composed of 10% peel powder of unripe banana (Musa sapientum) combined with lemongrass (Cymbopogon citratus) oil, at 0.1% concentration, in patients with chronic ulcers.